PTC Therapeutics Inc (NASDAQ:PTCT)

25.52
Delayed Data
As of 4:00pm ET
 -0.14 / -0.55%
Today’s Change
8.12
Today|||52-Week Range
28.75
+53.00%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close25.66
Today’s open25.74
Day’s range24.35 - 26.34
Volume573,229
Average volume (3 months)969,117
Market cap$1.1B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+17.75%
Earnings growth (this year)+48.60%
Earnings growth (next 5 years)--
Revenue growth (last year)+124.95%
P/E ratioNM
Price/Sales4.49
Price/Book7.33

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.15+3.04%
TGTXTG Therapeutics Inc+0.05+0.36%
BYSIBeyondspring Inc-0.91-3.51%
EGRXEagle Pharmaceutical...+1.84+2.83%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$82.7M
Annual profit (last year)-$142.1M
Net profit margin-171.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts